RecruitingNot ApplicableNCT07588243

A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

A Pivotal Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

Sponsor

CynosureLutronic

Enrollment

44 participants

Start Date

Feb 19, 2026

Study Type

INTERVENTIONAL

Conditions

Androgenic alopecia

Summary

The goal of this clinical study is to evaluate the efficacy and safety of the Ultra device for the treatment of hair regrowth by assessing the improvement of hair density and hair shaft diameter.

Eligibility

Min Age: 22 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Low Level Laser Therapy for people with androgenic alopecia. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 22 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.